Drug Candidates for Gastric Cancer
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (23 February 2023) | Viewed by 2698
Special Issue Editors
Interests: gastric cancer; drug discovery process; artificial intelligence; drug repurposing; biomarker discovery
Special Issue Information
Dear Colleagues,
Our understanding of the biology of gastric cancer (GC) has substantially improved over the last decade, leading to advances in targeted therapies and novel therapeutic approaches.
Recent breakthroughs in potential therapeutic candidates for GC, as well as innovations in neoadjuvant and adjuvant chemotherapy, immunotherapy, and radiation treatment for GC, will be discussed in this Special Issue. This Special Issue will also discuss the roles of emerging therapeutics in both clinical and investigational fields, such as rational and structure-based drug design, which have the potential to improve the clinical outcome of these illnesses. Reviews and research papers are both welcome.
Regarding GC, potential topics include, but are not limited to, the following: experimental therapeutics, drug candidates, drug repurposing, drug target discovery, drug screening, artificial intelligence in drug discovery, computational methods for drug repurposing and drug design, molecular dynamics, and molecular docking.
Dr. Seungyoon Nam
Dr. Jinhyuk Lee
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gastric cancer
- drug candidates
- drug discovery
- drug repurposing
- drug screening
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
